DE69839393D1 - Stimulierung, züchtung und erhalt pankreatischer und anderer zellen - Google Patents

Stimulierung, züchtung und erhalt pankreatischer und anderer zellen

Info

Publication number
DE69839393D1
DE69839393D1 DE69839393T DE69839393T DE69839393D1 DE 69839393 D1 DE69839393 D1 DE 69839393D1 DE 69839393 T DE69839393 T DE 69839393T DE 69839393 T DE69839393 T DE 69839393T DE 69839393 D1 DE69839393 D1 DE 69839393D1
Authority
DE
Germany
Prior art keywords
cells
stimulation
cellulose derivative
pancreatic beta
pancreatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69839393T
Other languages
English (en)
Other versions
DE69839393T2 (de
Inventor
Per Mansson
Tomas Lundin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ascendia AB
Original Assignee
Ascendia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascendia AB filed Critical Ascendia AB
Publication of DE69839393D1 publication Critical patent/DE69839393D1/de
Application granted granted Critical
Publication of DE69839393T2 publication Critical patent/DE69839393T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
DE69839393T 1997-03-18 1998-03-16 Stimulierung, züchtung und erhalt pankreatischer und anderer zellen Expired - Lifetime DE69839393T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9700983A SE9700983D0 (sv) 1997-03-18 1997-03-18 Stimulering, odling och preservation av pankreas- och andra celler
SE9700983 1997-03-18
PCT/SE1998/000475 WO1998041617A1 (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic and other cells

Publications (2)

Publication Number Publication Date
DE69839393D1 true DE69839393D1 (de) 2008-06-05
DE69839393T2 DE69839393T2 (de) 2009-06-04

Family

ID=20406207

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69839393T Expired - Lifetime DE69839393T2 (de) 1997-03-18 1998-03-16 Stimulierung, züchtung und erhalt pankreatischer und anderer zellen

Country Status (9)

Country Link
US (1) US6479283B1 (de)
EP (1) EP0975739B1 (de)
JP (1) JP4237265B2 (de)
AT (1) ATE393214T1 (de)
AU (1) AU6431398A (de)
CA (1) CA2283676C (de)
DE (1) DE69839393T2 (de)
SE (1) SE9700983D0 (de)
WO (1) WO1998041617A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60116500T2 (de) * 2000-06-28 2006-09-21 Ascendia Ab Dna/rna-einbettungsmedium und verfahren zur verwendung
US20040186180A1 (en) 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
JP2010506957A (ja) * 2006-10-20 2010-03-04 ダウ グローバル テクノロジーズ インコーポレイティド メタボリックシンドロームを予防または処置するための水溶性セルロース誘導体の使用
EP2162531B1 (de) * 2007-05-04 2019-01-16 Ascendia AB Verfahren und mittel zur kultivierung von osteoblasten
WO2009111022A1 (en) * 2008-03-07 2009-09-11 Corning Incorporated Hydrophobically modified cellulose ether derivatives for cell culture and release
KR20120100962A (ko) 2009-10-02 2012-09-12 박스터 헬쓰케어 에스.에이. 신장 손상을 치료하는데 사용하기 위한 조혈 줄기 세포
JP2014519854A (ja) 2011-06-23 2014-08-21 ザ チルドレンズ ホスピタル オブ フィラデルフィア ヒト多能性幹細胞から生じる自己複製する内胚葉前駆細胞株とその使用方法
US20130216495A1 (en) 2012-02-21 2013-08-22 Baxter Healthcare Sa Pharmaceutical composition comprising cd34+ cells
EP3167911A1 (de) * 2015-11-10 2017-05-17 Oniris In si-hpmc-eingekapselte insulinerzeugende zellen zur behandlung von typ-1-diabetes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038139A (en) * 1976-07-16 1977-07-26 G. D. Searle & Co., Limited Cell culture medium
US4104124A (en) * 1976-08-30 1978-08-01 Louisiana State University Foundation Process for the production of single cell protein and amino acids
DE2726313C3 (de) * 1977-06-10 1980-02-07 Battelle-Institut E.V., 6000 Frankfurt Verfahren zur in-vitro-Biosynthese von Hormonen, insbesondere von Insulin
US4330622A (en) * 1979-09-12 1982-05-18 Becton Dickinson & Co. Elimination of non-microbial turbidity in culture media
JPS56167624A (en) * 1980-05-29 1981-12-23 Toray Ind Inc Method of interferon production
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
DD282471A5 (de) * 1989-04-21 1990-09-12 Staatliches Inst Fuer Immunpra Verfahren zur kultivation von mikroorganismen
JPH03175973A (ja) * 1989-09-26 1991-07-31 Kirin Brewery Co Ltd 動物細胞培養用担体およびその製造法
DE4115722A1 (de) * 1991-05-14 1992-11-19 Boehringer Mannheim Gmbh Serumfreies medium zur kultivierung von saeugerzellen
IL102929A (en) * 1992-08-24 1996-11-14 Interpharm Lab Ltd Serum-free medium for mammalian cells
US5834308A (en) * 1994-04-28 1998-11-10 University Of Florida Research Foundation, Inc. In vitro growth of functional islets of Langerhans
US5587309A (en) * 1994-04-29 1996-12-24 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating proliferation and differentiation of human fetal pancreatic cells ex vivo

Also Published As

Publication number Publication date
AU6431398A (en) 1998-10-12
SE9700983D0 (sv) 1997-03-18
JP4237265B2 (ja) 2009-03-11
JP2001521377A (ja) 2001-11-06
WO1998041617A1 (en) 1998-09-24
CA2283676C (en) 2004-11-02
EP0975739A1 (de) 2000-02-02
EP0975739B1 (de) 2008-04-23
ATE393214T1 (de) 2008-05-15
US6479283B1 (en) 2002-11-12
CA2283676A1 (en) 1998-09-24
DE69839393T2 (de) 2009-06-04

Similar Documents

Publication Publication Date Title
ATE142691T1 (de) Proteine mit faktor-viii-aktivität, verfahren zu deren herstellung unter verwendung von genetisch modifizierten zellen und diese enthaltende pharmazeutische zusammensetzungen
ATE204176T1 (de) Verwendung von insulinähnlichen wachstumsfaktoren und analogen zur behandlung von erkrankungen der sehnerven
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
DE69839393D1 (de) Stimulierung, züchtung und erhalt pankreatischer und anderer zellen
NO940597L (no) Isolering, vekst, differensiering og genslöyd på menneskers muskelceller
ATA71295A (de) Verwendung einer vorrichtung zum halten und abgeben einer homogenen cellulosesuspension
MEP48108A (en) 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
DE60026568D1 (de) Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung
ATE186835T1 (de) Herstellung von formulierungen zur arzneiverabreichung mittels elektrotransport
ATE513588T1 (de) Verwendung eines pyridindicarbosäurederivates oder eines salzes davon, zur stimulation oder anregung von keratinischen faserwachstum und/oder zur verhinderung von dessen verlust
IS6105A (is) Aðferð til meðferðar á netjuhersli með notkun mótlyfs við integríninu alfa-4
DK0850298T3 (da) Nervetransplantation under anvendelse af pluripotente neuroepitelceller
ATE459355T1 (de) Verfahren zur behandlung von erkrankungen mit mangel an thiolhaltiger verbindung
DE69630879D1 (de) Biologisch abbaubare vorrichtung
BR8202494A (pt) Processo para preparar tecido natural fixo bem como tecido natural fixo valvula cardiaca fixa de suino e tecido fixo de pericardio de bovino adequados para implante
Liu et al. Isolation and serial cultivation of rabbit skin epithelial cells
FR2767527B1 (fr) Derives de piperazines indoliques, utiles comme medicaments et procede de preparation
PT935652E (pt) Produtos de factor de crescimento de queratinocitos-2
DK1509523T3 (da) Triazaspiro-forbindelser anvendelige for at behandle eller forhindre smerte
DK1225906T3 (da) Mekanisk forlængede nerveceller og fremgangsmåde til at producere og anvende disse celler
SE9503620L (sv) Användning av proteinet S-100b för framställning av läkemedel för nervceller
BR9911678A (pt) Cristais de semeadura para a preparação de peptìdeos ou preteìnas.
NO20063353L (no) 1,2,3,4-tetrahydroisokinolinderivater, fremgangsmate for fremstilling derav og anvendelser derav
RU94003799A (ru) Способ лечения псороптозов животных

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R079 Amendment of ipc main class

Ref document number: 975739

Country of ref document: EP

Free format text: PREVIOUS MAIN CLASS: C12N0005080000

Ipc: C12N0005071000